{
  "schema_version": "0.1.0",
  "case_id": "HR-ML032",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML032",
    "display_name": "Gwen Ifill",
    "aliases": [
      "Gwendolyn Ifill"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1955-09-29",
          "display": "September 29, 1955",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1955",
              "display": "1955",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with The Washington Post and NPR."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2016-11-14",
          "display": "November 14, 2016",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2016",
              "display": "2016",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the obituaries."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML032-SYN",
      "ssn": "000-32-5814",
      "date_of_birth": "1965-09-29",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Lorna Achebe-Price, MD",
      "fictional_consultant": {
        "name": "Miriam Delacroix, MD",
        "specialty": "Gynecologic Oncology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1955-09-29",
        "display": "September 29, 1955",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Queens, New York.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1977",
        "display": "1977",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Graduates from Simmons College; hired by the Boston Herald American.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1999",
        "display": "1999",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Becomes moderator of Washington Week in Review and a NewsHour senior correspondent.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "2004",
        "display": "2004",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moderates the vice-presidential debate and asks about AIDS among Black women.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "2009",
        "display": "2009",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Publishes The Breakthrough.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "2013",
        "display": "2013",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Named co-anchor of the PBS NewsHour.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "2016-04-07",
        "display": "April 7, 2016",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Announces a leave of a few weeks for health reasons; returns by the start of June.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "2016-11-14",
        "display": "November 14, 2016",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at a hospice in Washington, D.C., at 61; her family gives the cause as endometrial cancer, and friends describe a diagnosis at the turn of the year and treatment kept private.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0007"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Gwendolyn Ifill was born in Queens, New York, on September 29, 1955, the fifth of six children. Her father, a Panamanian immigrant, became a pastor in the African Methodist Episcopal Church; her mother was from Barbados. The family moved around the Northeast for her father's work and for a time lived in federally subsidized housing.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Gwendolyn Ifill was born in Queens, on Sept. 29, 1955"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "born in New York City in 1955; both parents immigrants; federally subsidized housing"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth year 1955"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She graduated from Simmons College in Boston in 1977. As a college intern at the Boston Herald American she found a racist note left for her; the paper's editors hired her after she graduated. She went on to report for the Baltimore Evening Sun, The Washington Post, The New York Times and NBC News.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history: a journalist who met racism early in her career and built one of the most respected careers in American news.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "internship at The Boston Herald; hired after her 1977 graduation"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Simmons College 1977; Baltimore Evening Sun 1981; The Post 1984; the Times; NBC 1994"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1999 she became moderator of PBS's Washington Week in Review, the first African American woman to host a major national political talk show, and a senior correspondent for the NewsHour. In 2013 she and Judy Woodruff were named co-anchors of the PBS NewsHour, the first women to jointly lead a national nightly news broadcast.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her work as an anchor and moderator anchors the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "moderator of Washington Week in Review in 1999; co-anchor of the NewsHour in 2013"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "17 years on the NewsHour and as moderator and managing editor of Washington Week"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "She moderated the vice-presidential debates of 2004 and 2008. In the 2004 debate she asked the candidates about AIDS in the United States, citing the much higher death rate among Black women aged 25 to 44. She wrote The Breakthrough: Politics and Race in the Age of Obama (2009).",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her question in the 2004 debate drew national attention to a health disparity affecting Black women; the modern episode teaches another one.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "black women between the ages of 25 and 44 are 13 times more likely to die of the disease"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "best-selling author of The Breakthrough"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "On April 7, 2016, she told viewers she would be off the air for a few weeks; PBS described the reason as health issues it did not specify, and in May said she was doing well and expected to return around Memorial Day. She was back on the air by the start of June, when she interviewed President Obama.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The first public sign of her illness, three months after the modern index visit. The illness itself was not named in public until her death.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "told viewers on April 7 she would be off for the next few weeks; undisclosed health issue; return around Memorial Day"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "In April, she had to take a leave of absence for what were described as ongoing health issues; returned in May"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "context",
          "locator": "interview with President Obama, June 1, 2016"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "She kept her illness private. After her death a close friend said she had been diagnosed with cancer at the end of 2015 or early in 2016, had told family and friends, and that the April leave was due to complications of treatment; another friend described her keeping up her work through chemotherapy. PBS said she died after several months of cancer treatment.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern episode. These are friends' accounts and an official statement given after her death; the stage, histology and treatment of her cancer were never made public.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "diagnosed with cancer sometime at the end of 2015 or early in 2016; chose to keep the cancer battle private; absence due to complications from the treatment"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "chemotherapy on Thursday, Washington Week on Friday"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "following several months of cancer treatment"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "She was a private person. She'd been fighting cancer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "She took a second leave shortly before her death and died at a hospice in Washington, D.C., on November 14, 2016, at 61. Her family gave the cause as endometrial cancer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented disease to which the synthetic diagnosis is linked. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died Nov. 14 at a hospice center in Washington, D.C.; the cause was endometrial cancer, said a family member"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "battling endometrial cancer; hospice care in Washington, D.C.; another leave of absence last week"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "died from complications of cancer"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "died at 61"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Bernstein A. Gwen Ifill, journalist who became staple of public affairs TV shows, dies at 61 (The Washington Post)",
      "publisher": "Anchorage Daily News",
      "url": "https://www.adn.com/nation-world/2016/11/14/prominent-pbs-journalist-gwen-ifill-dead-at-61-after-illness/",
      "source_type": "other",
      "published": "2016-11-14",
      "accessed": "2026-11-04",
      "rights_note": "Newspaper obituary syndicated from The Washington Post; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Byers D, Stelter B. PBS newscaster Gwen Ifill has died (CNNMoney)",
      "publisher": "KSL.com",
      "url": "https://www.ksl.com/article/42209265",
      "source_type": "other",
      "published": "2016-11-14",
      "accessed": "2026-11-04",
      "rights_note": "News report syndicated from CNN, quoting a close friend and the head of WETA; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Remembering Gwen",
      "publisher": "PBS NewsHour",
      "url": "https://www.pbs.org/newshour/nation/remembering-gwen",
      "source_type": "other",
      "published": "2016-11-14",
      "accessed": "2026-11-04",
      "rights_note": "Official statement and obituary from her program; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Ulaby N. PBS News Anchor Gwen Ifill Dies At 61 (All Things Considered)",
      "publisher": "NPR",
      "url": "https://www.npr.org/2016/11/14/502051018/pbs-news-anchor-gwen-ifill-dies-at-61",
      "source_type": "other",
      "published": "2016-11-14",
      "accessed": "2026-11-04",
      "rights_note": "Broadcast obituary transcript; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Ehrbar N. Gwen Ifill, \"PBS NewsHour\" anchor, is dead at 61",
      "publisher": "CBS News",
      "url": "https://www.cbsnews.com/news/gwen-ifill-pbs-newshour-anchor-is-dead-at-61/",
      "source_type": "other",
      "published": "2016-11-15",
      "accessed": "2026-11-04",
      "rights_note": "News report quoting the PBS NewsHour statement; used for the statement's wording."
    },
    {
      "source_id": "SRC-0006",
      "title": "PBS' Gwen Ifill, on leave, expected to return in 2 weeks (The Associated Press)",
      "publisher": "InfoNews",
      "url": "https://infonews.ca/?p=1827610",
      "source_type": "other",
      "published": "2016-05-16",
      "accessed": "2026-11-04",
      "rights_note": "Wire report published during her life; used for the April leave and the expected return."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-01-05",
    "index_age": 60,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Evaluate postmenopausal bleeding at once, as any bleeding after menopause requires, in a 60-year-old Black woman, whose risk of dying of endometrial cancer is about twice that of White women because of later diagnosis, more aggressive non-endometrioid and p53-abnormal tumors, and delays in evaluating bleeding: transvaginal ultrasound together with endometrial sampling at the first evaluation (the ACOG update that no longer relies on a thin endometrium alone); histology with the molecular classification (POLE, mismatch repair, p53) that the FIGO 2023 staging uses; CT staging; gynecologic oncology care with minimally invasive hysterectomy and sentinel lymph node mapping; treatment chosen by stage and molecular class, here dostarlimab with carboplatin and paclitaxel for mismatch repair deficient stage IIIC2 disease, with immune-related adverse event monitoring; universal Lynch syndrome tumor screening with MLH1 promoter methylation testing and genetic counseling; and survivorship care, on the NCCN uterine neoplasms guideline, the ACOG postmenopausal bleeding guidance, the SGO surveillance statement and the CMID endometrial cancer monograph.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-01-05",
        "purpose": "Three weeks of postmenopausal bleeding in a woman of 60: examination, office endometrial biopsy, transvaginal ultrasound, and gynecologic oncology review booked"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-01-20",
        "purpose": "Biopsy result: endometrial cancer; staging CT, gynecologic oncology consultation, Lynch syndrome tumor screening, and preparation for surgery"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-02-24",
        "purpose": "Review three weeks after surgical staging: final pathology and molecular class, genetic counseling, and the first cycle of dostarlimab with carboplatin and paclitaxel"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-04-28",
        "purpose": "Midpoint of combination treatment: blood counts, immune-related adverse event checks, neuropathy, and mood"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-06-30",
        "purpose": "End of combination treatment: response CT, immune-related hypothyroidism, the first maintenance dostarlimab dose, and the survivorship plan"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-08-11",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Postmenopausal bleeding for three weeks, about eight years after her last period, in a woman of 60 who takes no hormone therapy: endometrial cancer must be excluded. Office endometrial biopsy taken today, transvaginal ultrasound this week, and gynecologic oncology review booked",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N95.0",
            "display": "Postmenopausal bleeding",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting problem; no symptom of her real illness was made public. Superseded by the diagnosis at the gynecologic oncology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-01-20"
      },
      {
        "id": "PRB-002",
        "display": "Endometrioid adenocarcinoma of the endometrium, FIGO grade 2, mismatch repair deficient (loss of MLH1 and PMS2 staining), p53 wild-type pattern, on office endometrial biopsy, with enlarged right pelvic and para-aortic lymph nodes on CT; surgical staging planned; synthetic modern detail linked to her publicly reported endometrial cancer",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C54.1",
            "display": "Malignant neoplasm of endometrium",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic histology, molecular result and extent; her family gave endometrial cancer as the cause of death (D), and nothing more about it was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-01-20"
      },
      {
        "id": "PRB-003",
        "display": "Metastatic endometrioid carcinoma in the right external iliac sentinel lymph node (9 mm deposit) and a left para-aortic lymph node (14 mm deposit), with the other nodes removed negative: FIGO 2023 stage IIIC2ii",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C77.8",
            "display": "Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nodal disease found at surgical staging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-24"
      },
      {
        "id": "PRB-004",
        "display": "Chemotherapy-induced peripheral neuropathy from paclitaxel: tingling in the toes, grade 1 (sensory only, no effect on daily activities)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G62.0",
            "display": "Drug-induced polyneuropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic common effect of paclitaxel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-28"
      },
      {
        "id": "PRB-005",
        "display": "Immune-related primary hypothyroidism from dostarlimab: TSH 11.8 with a low free T4, tiredness and feeling cold (grade 2)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E03.2",
            "display": "Hypothyroidism due to medicaments and other exogenous substances",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic immune-related adverse event, among the most common with PD-1 inhibitors.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-30"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Two tablets every 6 hours as needed"
        },
        "start_date": "2026-02-03",
        "end_date": "2026-02-17",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic pain relief after minimally invasive surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Dostarlimab 50 mg/mL injection, 500 mg intravenously over 30 minutes on day 1 of each 21-day cycle, before carboplatin and paclitaxel, for six cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2539972",
            "display": "10 ML dostarlimab-gxly 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 500,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Day 1 every 21 days for six cycles"
        },
        "start_date": "2026-02-24",
        "end_date": "2026-06-09",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic PD-1 inhibitor with chemotherapy for mismatch repair deficient stage IIIC2 endometrial cancer (RUBY regimen).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Carboplatin 10 mg/mL injection, 575 mg (AUC 5) intravenously on day 1 of each 21-day cycle, for six cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "597195",
            "display": "carboplatin 10 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 575,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Day 1 every 21 days for six cycles"
        },
        "start_date": "2026-02-24",
        "end_date": "2026-06-09",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic platinum chemotherapy; dose by the Calvert formula from an estimated creatinine clearance of about 90 mL/min.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Paclitaxel 6 mg/mL injection, 320 mg (175 mg/m2) intravenously over 3 hours on day 1 of each 21-day cycle, for six cycles, after dexamethasone, diphenhydramine and famotidine",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312199",
            "display": "paclitaxel 6 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 320,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Day 1 every 21 days for six cycles"
        },
        "start_date": "2026-02-24",
        "end_date": "2026-06-09",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic taxane chemotherapy; body surface area 1.82 m2.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet every 8 hours as needed for nausea"
        },
        "start_date": "2026-02-24",
        "end_date": "2026-06-30",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic rescue antiemetic during chemotherapy; the three-drug preventive regimen is given in the infusion center.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Dostarlimab 50 mg/mL injection, 1000 mg intravenously over 30 minutes every 6 weeks as maintenance, for up to three years",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2539972",
            "display": "10 ML dostarlimab-gxly 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 6,
          "period_unit": "wk",
          "text": "Every 6 weeks"
        },
        "start_date": "2026-06-30",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic maintenance immunotherapy after six combination cycles.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Levothyroxine 75 mcg oral tablet, one tablet daily before breakfast",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "966222",
            "display": "levothyroxine sodium 0.075 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily before breakfast"
        },
        "start_date": "2026-06-30",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic thyroid replacement for immune-related hypothyroidism.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 11.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; mild anemia after three weeks of bleeding. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 6.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; mild anemia after three weeks of bleeding. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 268,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; mild anemia after three weeks of bleeding. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 0.82,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney function and glucose at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 82,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney function and glucose at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney function and glucose at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-05",
        "value": 5.5,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c; diabetes is a risk factor for endometrial cancer and is excluded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-01-05",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V2",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 12.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V2",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 6.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V2",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 3.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V2",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 274,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V2",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 84,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 19,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V2",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V2",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V2",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chemistry before surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA125-V2",
        "display": "Cancer Ag 125 [Units/volume] in Serum or Plasma",
        "label": "CA-125",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-20",
        "value": 28,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10334-1",
            "display": "Cancer Ag 125 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic CA-125 at diagnosis; normal, so it will not be used for follow-up.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-01-20",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day the diagnosis was explained; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V2",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-01-20",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 on the day of the diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 11.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 6.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V3",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 3.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 301,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 0.78,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 87,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 0.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V3",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium before carboplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V3",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline TSH before dostarlimab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V3",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline free T4 before dostarlimab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-24",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 10.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 4.3,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V4",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 2.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 196,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 0.81,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 83,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 97,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V4",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 1.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium after three cycles of carboplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V4",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 4.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH before cycle 4; slightly above range, an early sign to watch on a checkpoint inhibitor.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V4",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 1.1,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic free T4 before cycle 4; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CORT-V4",
        "display": "Cortisol [Mass/volume] in Serum or Plasma",
        "label": "Cortisol (morning)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-28",
        "value": 12.6,
        "unit": "ug/dL",
        "reference_range": {
          "low": 5,
          "high": 23,
          "text": "Morning sample, drawn before 9 a.m."
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2143-6",
            "display": "Cortisol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic morning cortisol, drawn today because it was missed at baseline; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-28",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 11.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 4.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V5",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 2.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 228,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three weeks after cycle 6.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 0.84,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 80,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 90,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver function and glucose before the first maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V5",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 11.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH: immune-related primary hypothyroidism on dostarlimab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V5",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 0.7,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic free T4, just below range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-CORT-V5",
        "display": "Cortisol [Mass/volume] in Serum or Plasma",
        "label": "Cortisol (morning)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-30",
        "value": 13.1,
        "unit": "ug/dL",
        "reference_range": {
          "low": 5,
          "high": 23,
          "text": "Morning sample, drawn before 9 a.m."
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2143-6",
            "display": "Cortisol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic morning cortisol; normal, so the fatigue is not adrenal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-30",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V6",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 3.6,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH six weeks after starting levothyroxine; now in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-FT4-V6",
        "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
        "label": "Free T4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 1.2,
        "unit": "ng/dL",
        "reference_range": {
          "low": 0.8,
          "high": 1.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3024-7",
            "display": "Thyroxine (T4) free [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic free T4 on levothyroxine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V6",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT before the second maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V6",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 93,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting glucose before the second maintenance dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V6",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 204,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V6",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 124,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic LDL cholesterol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V6",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 58,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic HDL cholesterol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V6",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 110,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic triglycerides.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-08-11",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Office endometrial biopsy with a suction catheter (Pipelle), with a chaperone, after verbal consent: adequate tissue obtained; tolerated with mild cramping",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "386802000",
            "display": "Endometrial biopsy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-01-05",
          "end": "2026-01-05"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic office procedure at the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Transvaginal ultrasound of the pelvis: endometrium 16 mm, heterogeneous, with an irregular junction with the myometrium and internal blood flow; two small intramural fibroids (1.8 cm and 1.2 cm); ovaries normal for age; no free fluid",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "429915000",
            "display": "Transvaginal ultrasonography of pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-01-07",
          "end": "2026-01-07"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic imaging two days after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "CT of the chest, abdomen and pelvis with contrast: enlarged, heterogeneous uterine cavity; a 1.5 cm right external iliac lymph node and a 1.7 cm left para-aortic lymph node below the renal veins, both suspicious; no liver, lung, bone or peritoneal lesion; no ascites",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "418023006",
            "display": "CT of chest, abdomen and pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-01-13",
          "end": "2026-01-13"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic staging scan ordered when the biopsy result was telephoned.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-11",
          "end": "2026-08-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Screening mammogram, both breasts",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "24623002",
            "display": "Screening mammography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-25",
          "end": "2026-08-25"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic screening mammogram two weeks after the preventive visit; no abnormality (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Robotic-assisted total laparoscopic hysterectomy with removal of both fallopian tubes and ovaries and pelvic washings. Pathology: endometrioid adenocarcinoma, FIGO grade 2 (low grade), 4.2 cm, invading 65% of the myometrial thickness; no cervical stromal invasion; focal (not substantial) lymphovascular space invasion; tubes, ovaries and serosa free; washings negative. Mismatch repair deficient (loss of MLH1 and PMS2), MLH1 promoter hypermethylated, POLE wild-type, p53 wild-type; estrogen receptor positive. FIGO 2023 stage IIIC2ii, molecular class MMRd",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "414575003",
            "display": "Laparoscopic total abdominal hysterectomy and bilateral salpingo-oophorectomy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-03",
          "end": "2026-02-03"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic operation and pathology; nothing about her real treatment was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Sentinel lymph node mapping with indocyanine green, both sides of the pelvis: right external iliac sentinel node with a 9 mm metastasis; left obturator sentinel node negative on ultrastaging",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "396487001",
            "display": "Sentinel lymph node biopsy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-03",
          "end": "2026-02-03"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic sentinel node result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Excision of the enlarged left para-aortic lymph node seen on CT, with adjacent para-aortic nodes below the renal veins: 1 of 4 nodes involved (14 mm deposit)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "58347006",
            "display": "Excision of lymph node",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-03",
          "end": "2026-02-03"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic para-aortic node result.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Genetic counseling: universal Lynch syndrome tumor screening explained; MLH1 and PMS2 loss explained by MLH1 promoter hypermethylation, which is acquired in the tumor and not inherited; germline testing not indicated; she was told what would change that advice",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "79841006",
            "display": "Genetic counseling",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-24",
          "end": "2026-02-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic genetics visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "CT of the chest, abdomen and pelvis with contrast at the end of combination treatment: no enlarged pelvic or para-aortic lymph node, no vaginal cuff mass, no liver, lung, bone or peritoneal lesion; expected postoperative changes (no evidence of disease)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "418023006",
            "display": "CT of chest, abdomen and pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-23",
          "end": "2026-06-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic end-of-treatment imaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-08-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose: recommended for every adult from 50, and she is on cancer treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-08-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult over 50; second dose in two to six months.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)",
        "status": "completed",
        "date": "2026-08-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap; no dose recorded in the past ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Three weeks of postmenopausal bleeding in a woman of 60: examination, office endometrial biopsy, transvaginal ultrasound, and gynecologic oncology review booked",
        "status": "finished",
        "date": "2026-01-05",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Biopsy result: endometrial cancer; staging CT, gynecologic oncology consultation, Lynch syndrome tumor screening, and preparation for surgery",
        "status": "finished",
        "date": "2026-01-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Endometrial biopsy result and gynecologic oncology consultation",
          "hpi": {
            "narrative": "Ms. Ifill returns two weeks after her first visit. The transvaginal ultrasound two days after that visit showed a 16 mm heterogeneous endometrium with internal blood flow and two small fibroids. The endometrial biopsy taken at the first visit, telephoned to her four days later, shows endometrioid adenocarcinoma, FIGO grade 2, with loss of MLH1 and PMS2 staining and a wild-type p53 pattern. CT of the chest, abdomen and pelvis the next week showed an enlarged right external iliac lymph node and an enlarged left para-aortic node, with no disease in the liver, lungs, bones or peritoneum. Dr. Delacroix of gynecologic oncology saw her this morning. The bleeding has lessened to occasional spotting. She has no pain, bowel or bladder change, leg swelling or weight loss. She says she is shaken but glad the answer came quickly, and wants to keep working through treatment if she can. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Biopsy",
                "value": "Endometrioid adenocarcinoma, FIGO grade 2; MLH1 and PMS2 lost; p53 wild-type"
              },
              {
                "label": "Imaging",
                "value": "Ultrasound: endometrium 16 mm, heterogeneous. CT: enlarged right external iliac and left para-aortic nodes; no distant disease"
              },
              {
                "label": "Symptoms",
                "value": "Spotting only; no pain"
              },
              {
                "label": "Coordination",
                "value": "Gynecologic oncology seen today; surgery in two weeks"
              },
              {
                "label": "Her questions",
                "value": "Whether the nodes mean the cancer has spread, whether it is inherited, and whether she can keep working"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats or weight loss"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Occasional spotting; no urinary symptoms"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain or change in bowel habit"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No leg swelling or calf pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried and sleeping less; PHQ-9 6 and GAD-7 7; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 74.2 kg; blood pressure 132/82, pulse 84"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no mass or fluid"
            },
            {
              "system": "Pelvic",
              "finding": "Examined with Dr. Delacroix and a chaperone: small amount of blood at the cervical os; cervix normal; uterus mobile, slightly enlarged; no adnexal mass or parametrial thickening"
            },
            {
              "system": "Lymph nodes",
              "finding": "No inguinal or supraclavicular nodes"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Composed, direct and focused; anxious when talking about the nodes"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Endometrioid adenocarcinoma of the endometrium, FIGO grade 2, mismatch repair deficient",
              "assessment": "Endometrial cancer diagnosed four days after her first visit, because the bleeding was sampled at once and the ultrasound was done the same week. The enlarged pelvic and para-aortic nodes on CT suggest stage III disease, which surgery will settle. Dr. Delacroix recommends minimally invasive hysterectomy with removal of both tubes and ovaries, sentinel node mapping and removal of the enlarged nodes in two weeks; treatment after surgery will depend on the final stage and the molecular class. The loss of MLH1 and PMS2 is the universal Lynch syndrome screen; MLH1 promoter methylation testing has been sent on the biopsy to tell an acquired change from an inherited one. CA-125 28 U/mL is normal and will not be used for follow-up. Fit for surgery: albumin 4.1 g/dL, creatinine 0.80 mg/dL",
              "plan": [
                "Surgery with Dr. Delacroix in two weeks",
                "MLH1 promoter methylation on the biopsy; POLE sequencing on the surgical specimen",
                "Hepatitis B, hepatitis C and HIV tests drawn today, in case systemic treatment follows",
                "Genetic counseling once the methylation result is back"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Postmenopausal bleeding",
              "assessment": "Explained by the diagnosis made today; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Evaluation of any postmenopausal bleeding",
              "cadence": "At the first report",
              "status": "up_to_date",
              "detail": "Examined and sampled at the first visit, without a waiting period",
              "guideline_ids": [
                "GL-ACOG-PMB-2026",
                "GL-ACOG-CO734-2018",
                "GL-CLARKE-2022",
                "GL-DOLL-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Endometrial tissue sampling",
              "cadence": "At the first evaluation of postmenopausal bleeding, with transvaginal ultrasound",
              "status": "up_to_date",
              "detail": "Office biopsy at the first visit: endometrioid adenocarcinoma, FIGO grade 2",
              "guideline_ids": [
                "GL-ACOG-PMB-2026",
                "GL-ACOG-CO734-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Transvaginal ultrasound",
              "cadence": "At the first evaluation, together with sampling",
              "status": "up_to_date",
              "detail": "Endometrium 16 mm, heterogeneous, with blood flow; two small intramural fibroids",
              "guideline_ids": [
                "GL-ACOG-PMB-2026",
                "GL-ACOG-CO734-2018"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "Before primary treatment when high-grade or extrauterine disease is suspected",
              "status": "up_to_date",
              "detail": "Enlarged right external iliac and left para-aortic nodes; no distant disease",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Mismatch repair immunohistochemistry (universal Lynch syndrome tumor screen)",
              "cadence": "At diagnosis, on every endometrial cancer",
              "status": "up_to_date",
              "detail": "Loss of MLH1 and PMS2; MSH2 and MSH6 retained",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "MLH1 promoter methylation",
              "cadence": "Reflex when MLH1 is lost",
              "status": "ordered",
              "detail": "Sent on the biopsy today",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "p53 immunohistochemistry and POLE sequencing (molecular classification)",
              "cadence": "At diagnosis or on the surgical specimen",
              "status": "ordered",
              "detail": "p53 wild-type pattern on the biopsy; POLE to be sequenced on the surgical specimen",
              "guideline_ids": [
                "GL-FIGO-2023",
                "GL-NCCN-UTERINE-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA-125",
              "cadence": "At diagnosis; afterwards only if raised at diagnosis",
              "status": "completed_today",
              "detail": "28 U/mL, normal; not to be repeated routinely",
              "observation_ids": [
                "OBS-CA125-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count, chemistry and liver tests before surgery",
              "cadence": "Within 30 days before surgery",
              "status": "completed_today",
              "detail": "Hemoglobin 12.1 g/dL, white cells 6.0, neutrophils 3.6, platelets 274; sodium 139, potassium 4.3, creatinine 0.80 mg/dL, eGFR 84; ALT 19, AST 21, bilirubin 0.5, albumin 4.1",
              "observation_ids": [
                "OBS-HGB-V2",
                "OBS-WBC-V2",
                "OBS-ANC-V2",
                "OBS-PLT-V2",
                "OBS-NA-V2",
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-ALT-V2",
                "OBS-AST-V2",
                "OBS-TBIL-V2",
                "OBS-ALB-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before systemic cancer treatment",
              "status": "ordered",
              "detail": "Hepatitis B surface antigen, core antibody and surface antibody, hepatitis C antibody, and HIV drawn today",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Gynecologic oncology",
              "cadence": "Before any surgery for endometrial cancer",
              "status": "completed_today",
              "detail": "Seen this morning; recommendations in the consultation note",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Genetic counseling",
              "cadence": "At diagnosis when the tumor screen is abnormal",
              "status": "due",
              "detail": "After the methylation result, at the next visit",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 6 and GAD-7 7, mild, with worry about the diagnosis; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V2",
                "OBS-GAD7-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Information, support and privacy",
              "cadence": "At diagnosis and throughout",
              "status": "completed_today",
              "detail": "Plain explanation with written information; she chose who would be told and asked that notes go only to her clinicians",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Surgery in two weeks with Dr. Delacroix. Primary care review three weeks after surgery with the final pathology, the methylation and POLE results, and genetic counseling. Call for heavy bleeding, fever, or leg swelling",
          "guideline_ids": [
            "GL-NCCN-UTERINE-2026",
            "GL-ACOG-PMB-2026",
            "GL-ACOG-CO734-2018",
            "GL-FIGO-2023",
            "GL-ACOG-PB147",
            "GL-ASCO-HBV-2020",
            "GL-CLARKE-2022",
            "GL-DOLL-2020",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Review three weeks after surgical staging: final pathology and molecular class, genetic counseling, and the first cycle of dostarlimab with carboplatin and paclitaxel",
        "status": "finished",
        "date": "2026-02-24",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review three weeks after surgical staging, on the first treatment day",
          "hpi": {
            "narrative": "Ms. Ifill returns three weeks after robotic-assisted hysterectomy with removal of both tubes and ovaries, sentinel node mapping and removal of the enlarged para-aortic node. She went home the next morning, needed acetaminophen for about a week and nothing since, and has had no bleeding, fever, leg swelling or bladder trouble. She went back to work last week. The final pathology and molecular results are back, and the multidisciplinary tumor board reviewed them with Dr. Delacroix. She saw the genetic counselor this morning. She came today for her first cycle of dostarlimab with carboplatin and paclitaxel. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Operation",
                "value": "Minimally invasive; home the next day; port sites healed"
              },
              {
                "label": "Pathology",
                "value": "Endometrioid adenocarcinoma, grade 2, 65% myometrial invasion; right pelvic sentinel node and one para-aortic node involved"
              },
              {
                "label": "Stage and molecular class",
                "value": "FIGO 2023 stage IIIC2ii; POLE wild-type, MMRd, p53 wild-type"
              },
              {
                "label": "Lynch syndrome screen",
                "value": "MLH1 promoter hypermethylated: acquired, not inherited"
              },
              {
                "label": "Today",
                "value": "Cycle 1 of dostarlimab, carboplatin and paclitaxel"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight 72.6 kg"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No vaginal bleeding or discharge; no urinary symptoms"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, diarrhea or abdominal pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tingling or numbness in the hands or feet"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No calf pain or leg swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-9 5; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 124/78, pulse 80; weight 72.6 kg"
            },
            {
              "system": "Abdomen",
              "finding": "Port-site incisions healed without redness or hernia; soft, non-tender"
            },
            {
              "system": "Extremities",
              "finding": "No leg or genital swelling; calf circumferences equal (baseline for lymphedema)"
            },
            {
              "system": "Neurological",
              "finding": "Light touch, pinprick and vibration normal in the hands and feet; ankle reflexes present (baseline before paclitaxel)"
            },
            {
              "system": "Skin",
              "finding": "No rash (baseline before a checkpoint inhibitor)"
            },
            {
              "system": "Psychiatric",
              "finding": "Focused and well informed; asks detailed questions"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Endometrioid endometrial cancer, FIGO 2023 stage IIIC2ii, molecular class MMRd",
              "assessment": "Surgery confirmed nodal spread to the pelvis and the para-aortic region, stage IIIC2ii; the molecular class does not change the stage at stage III but chooses the treatment. For mismatch repair deficient advanced disease, adding a PD-1 inhibitor to carboplatin and paclitaxel greatly lowers the risk of progression, so the tumor board recommends dostarlimab with chemotherapy for six cycles, then dostarlimab alone. Radiation is not planned now and will be reconsidered only if the end-of-treatment CT shows residual nodal disease. Hepatitis B, hepatitis C and HIV tests were negative. Counts, kidney and liver function, magnesium, TSH and free T4 allow full-dose treatment: creatinine 0.78 mg/dL, estimated creatinine clearance about 90 mL/min",
              "plan": [
                "Cycle 1 today: dostarlimab 500 mg, then carboplatin AUC 5 (575 mg) and paclitaxel 175 mg/m2 (320 mg), every 21 days for six cycles",
                "Fosaprepitant, palonosetron and dexamethasone before each cycle; ondansetron at home as needed",
                "Temperature twice a day for a week after each cycle; call at once for 38.0 °C or more",
                "Report diarrhea, rash, cough, breathlessness or unusual tiredness at once: possible immune-related effects"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Pelvic and para-aortic nodal metastases",
              "assessment": "Both enlarged nodes removed; no other node involved. Lymphedema risk is low after sentinel mapping but not zero after para-aortic node removal",
              "plan": [
                "Lymphedema check at each visit; report leg or genital swelling"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Surgical pathology, stage and molecular class",
              "cadence": "After surgery",
              "status": "up_to_date",
              "detail": "FIGO 2023 stage IIIC2ii; POLE wild-type, MMRd, p53 wild-type; estrogen receptor positive",
              "guideline_ids": [
                "GL-FIGO-2023",
                "GL-NCCN-UTERINE-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "MLH1 promoter methylation",
              "cadence": "Reflex when MLH1 is lost",
              "status": "up_to_date",
              "detail": "Hypermethylated: the mismatch repair loss is acquired in the tumor",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Genetic counseling",
              "cadence": "When the tumor screen is abnormal",
              "status": "completed_today",
              "detail": "Seen this morning; the result was explained",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Germline testing for Lynch syndrome and cascade testing of relatives",
              "cadence": "If MMR loss is not explained by MLH1 methylation, or with a strong family history",
              "status": "not_indicated",
              "detail": "MLH1 loss is explained by promoter methylation; she knows that a new family history of colorectal or endometrial cancer at a young age would be a reason to revisit this",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-ACOG-PB147",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before systemic cancer treatment",
              "status": "up_to_date",
              "detail": "All negative; no antiviral prophylaxis needed",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before each chemotherapy cycle",
              "status": "completed_today",
              "detail": "Hemoglobin 11.6 g/dL, white cells 6.4, neutrophils 3.9, platelets 301",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-ANC-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and estimated kidney function (carboplatin dose)",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.78 mg/dL, eGFR 87; carboplatin 575 mg for AUC 5",
              "observation_ids": [
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (paclitaxel and checkpoint inhibitor)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "ALT 18, AST 20 U/L, bilirubin 0.4 mg/dL, albumin 4.0 g/dL",
              "observation_ids": [
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-TBIL-V3",
                "OBS-ALB-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "2.0 mg/dL",
              "observation_ids": [
                "OBS-MG-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 (immune-related thyroid disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "TSH 1.9 mIU/L, free T4 1.2 ng/dL (baseline)",
              "observation_ids": [
                "OBS-TSH-V3",
                "OBS-FT4-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose (immune-related diabetes)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "92 mg/dL (baseline)",
              "observation_ids": [
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Morning cortisol (immune-related adrenal and pituitary disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "deferred",
              "detail": "Not drawn: she arrived after the morning window, when a cortisol cannot be read. To be drawn before 9 a.m. before cycle 2 in the infusion center. No symptom of adrenal insufficiency",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy: symptoms and examination",
              "cadence": "Baseline and before each taxane cycle",
              "status": "completed_today",
              "detail": "Baseline normal before the first paclitaxel dose",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lymphedema",
              "cadence": "Each visit after lymph node surgery",
              "status": "completed_today",
              "detail": "No swelling; baseline calf measurements recorded",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Nausea and vomiting control",
              "cadence": "Each cycle",
              "status": "completed_today",
              "detail": "Three-drug preventive regimen for carboplatin (an NK1 antagonist, a 5-HT3 antagonist and dexamethasone); ondansetron at home",
              "guideline_ids": [
                "GL-ASCO-ANTIEMETIC-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Paclitaxel infusion reaction prevention",
              "cadence": "Each paclitaxel dose",
              "status": "completed_today",
              "detail": "Dexamethasone, diphenhydramine and famotidine before the infusion; observation in the first hour",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Immune-related adverse event teaching",
              "cadence": "Before the first checkpoint inhibitor dose and each visit",
              "status": "completed_today",
              "detail": "Wallet card and written list of symptoms to report the same day",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 5; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Cycles every 21 days in the infusion center, with blood counts, chemistry, TSH and a morning cortisol before cycle 2. Primary care and gynecologic oncology review at cycle 4. Call at once for a temperature of 38.0 °C or more, diarrhea, rash, cough or breathlessness",
          "guideline_ids": [
            "GL-NCCN-UTERINE-2026",
            "GL-FIGO-2023",
            "GL-RUBY-2023",
            "GL-GY018-2023",
            "GL-JEMPERLI-LABEL",
            "GL-ACOG-PB147",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-ANTIEMETIC-2020",
            "GL-ASCO-CIPN-2020",
            "GL-ASCO-HBV-2020",
            "GL-SGO-SURV-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Midpoint of combination treatment: blood counts, immune-related adverse event checks, neuropathy, and mood",
        "status": "finished",
        "date": "2026-04-28",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review at the midpoint of combination treatment, on the day of cycle 4",
          "hpi": {
            "narrative": "Ms. Ifill returns on the day of her fourth cycle. Cycles 2 and 3 were given on schedule in the infusion center. Nausea lasts a day or two after each cycle and is controlled with ondansetron two or three times. For about two weeks she has had tingling in her toes that does not affect walking or balance. Her hair has thinned and she wears a wig. She has had no diarrhea, rash, cough, breathlessness or headache. She is tired for two or three days after each cycle and works from home on those days. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Cycle 4 of 6 today; cycles 2 and 3 on schedule"
              },
              {
                "label": "Nausea",
                "value": "One or two days after each cycle; controlled"
              },
              {
                "label": "Neuropathy",
                "value": "Tingling in the toes for two weeks; no effect on function"
              },
              {
                "label": "Immune-related symptoms",
                "value": "None"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 5"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired for two or three days after each cycle; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea for one or two days after each cycle; no vomiting or diarrhea"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Tingling in the toes; no weakness or falls; no headache"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Hair thinning; no rash or itching"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No heat or cold intolerance; no thirst"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 71.8 kg; blood pressure 120/76, pulse 82"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no mass"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling; calf circumferences unchanged"
            },
            {
              "system": "Neurological",
              "finding": "Pinprick slightly reduced over the toes; vibration sense and ankle reflexes present; strength normal; steady gait"
            },
            {
              "system": "Skin",
              "finding": "Hair thinning; no rash"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and composed"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Endometrioid endometrial cancer, stage IIIC2ii, MMRd, on dostarlimab with carboplatin and paclitaxel",
              "assessment": "Tolerating treatment. Counts allow cycle 4: neutrophils 2.1, platelets 196; hemoglobin 10.6 g/dL, mild anemia from chemotherapy without symptoms. Kidney and liver function are normal; magnesium 1.8 mg/dL. TSH 4.8 is just above range with a normal free T4 of 1.1: an early thyroid change to watch, which needs no treatment now. Morning cortisol 12.6 is normal",
              "plan": [
                "Cycle 4 today at full dose",
                "TSH and free T4 before each remaining cycle",
                "CT of the chest, abdomen and pelvis two weeks after cycle 6"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chemotherapy-induced peripheral neuropathy, grade 1",
              "assessment": "Grade 1 sensory neuropathy from paclitaxel without functional effect. No medicine prevents it; the paclitaxel dose is reduced if it begins to interfere with daily activities (grade 2) or becomes painful",
              "plan": [
                "Continue paclitaxel at full dose with a check before each cycle",
                "Report trouble with buttons, writing or balance, or burning pain",
                "Duloxetine if it becomes painful"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before each chemotherapy cycle",
              "status": "completed_today",
              "detail": "Hemoglobin 10.6 g/dL, white cells 4.3, neutrophils 2.1, platelets 196; cycle 4 can be given. Cycles 2 and 3 were given on schedule in the infusion center",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-ANC-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and estimated kidney function (carboplatin dose)",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "Creatinine 0.81 mg/dL, eGFR 83; carboplatin dose unchanged",
              "observation_ids": [
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (paclitaxel and checkpoint inhibitor)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "ALT 24, AST 26 U/L, bilirubin 0.5 mg/dL",
              "observation_ids": [
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-TBIL-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium",
              "cadence": "Before each cycle",
              "status": "completed_today",
              "detail": "1.8 mg/dL",
              "observation_ids": [
                "OBS-MG-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 (immune-related thyroid disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "TSH 4.8 mIU/L, just above range, with free T4 1.1 ng/dL: watch before each cycle",
              "observation_ids": [
                "OBS-TSH-V4",
                "OBS-FT4-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose (immune-related diabetes)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "97 mg/dL",
              "observation_ids": [
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Morning cortisol (immune-related adrenal and pituitary disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "deferred",
              "detail": "12.6 ug/dL today, normal. A deviation: the baseline cortisol deferred at cycle 1 was not drawn before cycles 2 and 3 either, because the request was not carried into the infusion center's standing orders. No harm resulted: today's value is normal and she has had no symptom of adrenal insufficiency. Corrective action: morning cortisol added to the standing orders before every remaining dose; no earlier values are recorded",
              "observation_ids": [
                "OBS-CORT-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy: symptoms and examination",
              "cadence": "Baseline and before each taxane cycle",
              "status": "completed_today",
              "detail": "Grade 1 sensory neuropathy; full dose continues",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lymphedema",
              "cadence": "Each visit after lymph node surgery",
              "status": "completed_today",
              "detail": "No swelling; calf measurements unchanged",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse event symptoms (diarrhea, rash, cough, breathlessness, fatigue, headache)",
              "cadence": "Each visit on a checkpoint inhibitor",
              "status": "completed_today",
              "detail": "None reported; skin and chest normal",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Response imaging",
              "cadence": "At the end of combination treatment, or sooner for symptoms",
              "status": "not_indicated",
              "detail": "Not needed at the midpoint after complete resection, with no symptoms; CT after cycle 6",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Nausea and vomiting control",
              "cadence": "Each cycle",
              "status": "completed_today",
              "detail": "Controlled: nausea one or two days per cycle, no vomiting",
              "guideline_ids": [
                "GL-ASCO-ANTIEMETIC-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Paclitaxel infusion reaction prevention",
              "cadence": "Each paclitaxel dose",
              "status": "completed_today",
              "detail": "No reaction in three cycles; same premedication",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 5",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Cycles 5 and 6 every 21 days, with TSH, free T4 and a morning cortisol before each. CT about two weeks after cycle 6, then a review with the result and the first maintenance dose",
          "guideline_ids": [
            "GL-NCCN-UTERINE-2026",
            "GL-RUBY-2023",
            "GL-JEMPERLI-LABEL",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-CIPN-2020",
            "GL-ASCO-ANTIEMETIC-2020",
            "GL-SGO-SURV-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "End of combination treatment: response CT, immune-related hypothyroidism, the first maintenance dostarlimab dose, and the survivorship plan",
        "status": "finished",
        "date": "2026-06-30",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "End of combination treatment: CT result, thyroid tests, and the first maintenance dose",
          "hpi": {
            "narrative": "Ms. Ifill returns three weeks after her sixth and last cycle of combination treatment, all given on schedule. The CT a week ago shows no evidence of disease. Over the past month she has felt more tired than after earlier cycles, colder than usual, and a little slowed down, without low mood. The tingling in her toes is unchanged and does not affect walking. She has had no vaginal bleeding, pelvic pain, cough, breathlessness, diarrhea, rash, headache, dizziness or leg swelling. She saw Dr. Delacroix with the CT result and is ready to begin maintenance dostarlimab today. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Six cycles of dostarlimab, carboplatin and paclitaxel completed on schedule"
              },
              {
                "label": "Response",
                "value": "CT: no evidence of disease"
              },
              {
                "label": "New symptoms",
                "value": "Tiredness and feeling cold for a month"
              },
              {
                "label": "Neuropathy",
                "value": "Grade 1, unchanged"
              },
              {
                "label": "Today",
                "value": "First maintenance dose of dostarlimab 1000 mg"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired and feels cold; no fever or weight loss"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No vaginal bleeding or discharge"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No diarrhea, constipation or abdominal pain"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Tingling in the toes, unchanged; no headache or dizziness"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Cold intolerance; no thirst"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 4; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well but tired; weight 72.4 kg; blood pressure 122/78, pulse 64, temperature 36.4 °C"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged or tender"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender; no mass"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling; calf circumferences unchanged"
            },
            {
              "system": "Neurological",
              "finding": "Pinprick slightly reduced over the toes only; ankle reflexes present with a slow relaxation phase; steady gait"
            },
            {
              "system": "Psychiatric",
              "finding": "Alert and engaged"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Endometrioid endometrial cancer, stage IIIC2ii, MMRd, no evidence of disease after combination treatment",
              "assessment": "No evidence of disease on CT, so radiation is not needed. Maintenance dostarlimab continues every six weeks for up to three years. Counts have recovered: hemoglobin 11.4 g/dL, neutrophils 2.8, platelets 228. Kidney and liver function and glucose are normal. Dr. Delacroix and she agreed today's plan",
              "plan": [
                "Dostarlimab 1000 mg today, then every six weeks",
                "Survivorship care plan given: examination with a pelvic examination every three months for two years; CT every six months for three years; no routine vaginal cytology and no CA-125",
                "Report vaginal bleeding, pelvic or abdominal pain, cough, weight loss or leg swelling"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Immune-related primary hypothyroidism, grade 2",
              "assessment": "TSH 11.8 with free T4 0.7, below range, and tiredness, feeling cold and a slower pulse: primary hypothyroidism from dostarlimab, the most common immune-related endocrine effect. Morning cortisol 13.1 is normal, so adrenal insufficiency is not the cause of her tiredness and thyroid replacement can start safely. Dostarlimab can continue with replacement",
              "plan": [
                "Levothyroxine 75 mcg daily before breakfast, starting today",
                "TSH and free T4 in six weeks, then with every dose",
                "Thyroid hormone will probably be needed long term"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chemotherapy-induced peripheral neuropathy, grade 1",
              "assessment": "Stable after the last paclitaxel; expected to improve slowly",
              "plan": [
                "Review at each visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Response imaging (CT of the chest, abdomen and pelvis)",
              "cadence": "At the end of combination treatment",
              "status": "up_to_date",
              "detail": "A week ago: no evidence of disease",
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils and platelets",
              "cadence": "Before each cycle; at the end of treatment",
              "status": "completed_today",
              "detail": "Hemoglobin 11.4 g/dL, white cells 4.9, neutrophils 2.8, platelets 228; recovered",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-ANC-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and estimated kidney function",
              "cadence": "Before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "Creatinine 0.84 mg/dL, eGFR 80",
              "observation_ids": [
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (paclitaxel and checkpoint inhibitor)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "ALT 22, AST 24 U/L, bilirubin 0.5 mg/dL",
              "observation_ids": [
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-TBIL-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH and free T4 (immune-related thyroid disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "TSH 11.8 mIU/L and free T4 0.7 ng/dL: immune-related hypothyroidism; levothyroxine started",
              "observation_ids": [
                "OBS-TSH-V5",
                "OBS-FT4-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose (immune-related diabetes)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "90 mg/dL",
              "observation_ids": [
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Morning cortisol (immune-related adrenal and pituitary disease)",
              "cadence": "Baseline and before each checkpoint inhibitor dose",
              "status": "completed_today",
              "detail": "13.1 ug/dL, normal; drawn before 9 a.m. under the standing order",
              "observation_ids": [
                "OBS-CORT-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA-125",
              "cadence": "Only if raised at diagnosis",
              "status": "not_indicated",
              "detail": "Normal at diagnosis (28 U/mL)",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Peripheral neuropathy: symptoms and examination",
              "cadence": "At each visit after taxane treatment",
              "status": "completed_today",
              "detail": "Grade 1, stable",
              "guideline_ids": [
                "GL-ASCO-CIPN-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lymphedema",
              "cadence": "Each visit after lymph node surgery",
              "status": "completed_today",
              "detail": "No swelling",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Immune-related adverse event symptoms (diarrhea, rash, cough, breathlessness, fatigue, headache)",
              "cadence": "Each visit on a checkpoint inhibitor",
              "status": "completed_today",
              "detail": "Tiredness and cold intolerance, explained by hypothyroidism; no diarrhea, rash, cough or headache",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021",
                "GL-JEMPERLI-LABEL",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Pelvic examination",
              "cadence": "Every three months for two years",
              "status": "due",
              "detail": "With gynecologic oncology in three months",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Surveillance CT of the chest, abdomen and pelvis",
              "cadence": "Every six months for three years for stage III disease",
              "status": "due",
              "detail": "Next in six months",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Levothyroxine: timing and interactions",
              "cadence": "At the start",
              "status": "completed_today",
              "detail": "Take on an empty stomach before breakfast, four hours apart from calcium or iron",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 4",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Survivorship care plan",
              "cadence": "At the end of active treatment",
              "status": "completed_today",
              "detail": "Written plan: visit schedule, symptoms of recurrence to report, lymphedema signs, weight and activity, blood pressure, lipid and glucose care, and screening for other cancers",
              "guideline_ids": [
                "GL-SGO-SURV-2026",
                "GL-NCCN-UTERINE-2026",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Preventive visit in six weeks with TSH and free T4, on the day of the second maintenance dose. Gynecologic oncology examination in three months; CT in six months. Call for vaginal bleeding, pelvic pain, cough, diarrhea, rash or breathlessness",
          "guideline_ids": [
            "GL-NCCN-UTERINE-2026",
            "GL-RUBY-2023",
            "GL-JEMPERLI-LABEL",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-CIPN-2020",
            "GL-SGO-SURV-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-08-11",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on the clinic's online form before the visit and reviewed with her by Dr. Achebe-Price",
          "hpi": {
            "narrative": "Ms. Ifill is a 60-year-old journalist with stage IIIC2 mismatch repair deficient endometrial cancer, treated with surgery and six cycles of dostarlimab, carboplatin and paclitaxel, who comes for her yearly preventive visit six weeks after the end of combination treatment. The CT then showed no evidence of disease. She had her first maintenance dose of dostarlimab six weeks ago and has her second today. Since starting levothyroxine her energy has improved and she no longer feels cold. The tingling in her toes is slowly fading. She has had no vaginal bleeding or discharge, pelvic pain, cough, leg swelling or weight loss. She is working full days again, covering the election campaign, and walks most mornings.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 60"
              },
              {
                "label": "Endometrial cancer",
                "value": "No evidence of disease at the end of treatment; dostarlimab maintenance dose 2 today"
              },
              {
                "label": "Thyroid",
                "value": "Levothyroxine for six weeks; energy better"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 0"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and improving"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy and engaged at work; close friends and church community; low stress apart from the campaign schedule"
            },
            {
              "domain": "Substance use",
              "finding": "No tobacco; alcohol occasionally, within low-risk limits; no drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Brisk walk of 30 minutes on most mornings"
            },
            {
              "domain": "Nutrition",
              "finding": "Regular meals; trying to eat more vegetables and less takeout on long workdays"
            },
            {
              "domain": "Sleep",
              "finding": "Six to seven hours on work nights"
            },
            {
              "domain": "Falls and home safety",
              "finding": "No falls; numbness in the toes is fading; good lighting at home"
            },
            {
              "domain": "Sexual health",
              "finding": "Not sexually active at present; knows to report vaginal dryness or pain"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Seat belt and smoke alarms",
              "finding": "Always wears a seat belt; smoke alarms tested"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy improving; no fever or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No diarrhea, abdominal pain or blood in the stool"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No vaginal bleeding or discharge; no urinary symptoms"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump or nipple change"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain or swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Faint tingling in the toes, fading"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No longer feels cold; no thirst"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 73.0 kg; blood pressure 124/78; pulse 70"
            },
            {
              "system": "Neck",
              "finding": "Thyroid not enlarged or tender; no lymph nodes"
            },
            {
              "system": "Breasts",
              "finding": "Clinical breast examination with a chaperone, at her choice: no masses, skin or nipple changes, or axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Port-site scars healed; soft, non-tender; no mass"
            },
            {
              "system": "Lymph nodes",
              "finding": "No inguinal or supraclavicular nodes"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling; calf circumferences equal"
            },
            {
              "system": "Skin",
              "finding": "No rash or suspicious lesions"
            },
            {
              "system": "Neurological",
              "finding": "Pinprick slightly reduced over the toes only; vibration and ankle reflexes normal; steady gait"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and direct"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Mammogram ordered: screening every two years from 40 to 74. Cervical screening is no longer indicated after total hysterectomy, and vaginal cytology is not used to look for recurrence. Colorectal screening is due: the cancer's mismatch repair loss was acquired, so average-risk screening applies, and she chose a stool immunochemical test. Lipids: total cholesterol 204, LDL 124, HDL 58 mg/dL; ten-year risk estimated as below the statin threshold, with lifestyle advice. A1c 5.5% earlier this year",
              "plan": [
                "Mammogram in two weeks",
                "Stool immunochemical test kit given today",
                "Influenza and COVID-19 vaccines this autumn",
                "Second zoster dose in two to six months",
                "Bone density at 65, sooner if a fracture or new risk factor",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Endometrioid endometrial cancer, FIGO stage IIIC2ii, MMRd, no evidence of disease",
              "assessment": "No symptom or sign of recurrence. ALT 21 U/L and glucose 93 mg/dL before the second maintenance dose of dostarlimab, given today in the infusion center",
              "plan": [
                "Dostarlimab 1000 mg every six weeks",
                "Gynecologic oncology examination every three months; CT every six months for three years"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Immune-related hypothyroidism on dostarlimab",
              "assessment": "TSH 3.6 and free T4 1.2 on levothyroxine 75 mcg; symptoms resolved",
              "plan": [
                "Continue levothyroxine 75 mcg daily",
                "TSH and free T4 every six weeks with the dostarlimab doses"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "124/78 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0; PHQ-9 4 six weeks ago",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "Occasional use within low-risk limits",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "ordered",
              "detail": "Mammogram every two years from 40 to 74; none in the past two years on file; booked in two weeks",
              "guideline_ids": [
                "GL-USPSTF-BRCA-2024"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "not_indicated",
              "detail": "Total hysterectomy with removal of the cervix for endometrial cancer; routine vaginal cytology is not recommended for surveillance",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018",
                "GL-SGO-SURV-2026"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "No screening on file; the tumor's MLH1 loss is explained by promoter methylation, so average-risk screening applies; stool immunochemical test chosen, with colonoscopy if positive",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021",
                "GL-NCCN-UTERINE-2026"
              ]
            },
            {
              "service": "Diabetes and lipid screening",
              "status": "completed_today",
              "detail": "A1c 5.5% at intake; total cholesterol 204, LDL 124, HDL 58, triglycerides 110 mg/dL; ten-year risk below the statin threshold",
              "guideline_ids": [
                "GL-USPSTF-AB",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "HIV and hepatitis C screening",
              "status": "up_to_date",
              "detail": "Both negative before cancer treatment",
              "guideline_ids": [
                "GL-USPSTF-AB",
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "service": "Osteoporosis screening",
              "status": "not_indicated",
              "detail": "Age 60 without a fracture, steroid course or low body weight; bone density at 65",
              "guideline_ids": [
                "GL-USPSTF-OSTEO-2025"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoker",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Pneumococcal, zoster and Tdap vaccines",
              "status": "completed_today",
              "detail": "PCV20, recombinant zoster dose 1 and Tdap given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines, this season",
              "status": "due",
              "detail": "This autumn, when the season's vaccines arrive",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental and eye examinations",
              "status": "due",
              "detail": "Dental review and an eye examination advised this year",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment aimed at cure and control of her cancer, wants to be told plainly what is happening, and wants to make her own decisions. She named a health care agent, recorded in the confidential part of the chart and not named here, and asked that information about her health be shared only with the people she names. She chose not to record other treatment preferences today. To be revisited yearly or if her illness changes.",
          "follow_up": "Mammogram in two weeks; stool test result by phone. Dostarlimab every six weeks with TSH, free T4, liver tests and glucose. Gynecologic oncology examination every three months and CT every six months. Influenza and COVID-19 vaccines this autumn. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-USPSTF-BRCA-2024",
            "GL-USPSTF-CERV-2018",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-OSTEO-2025",
            "GL-CDC-IMZ-2026",
            "GL-SGO-SURV-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-01-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-01-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-02-24",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 72.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-04-28",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 71.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-06-30",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 72.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-08-11",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 73.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the preventive visit, seated.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:30:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Journalist and co-anchor of a nightly national news program; also moderates a weekly political program; long working days and frequent travel in an election year",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lives alone in Washington, D.C.; has no children. Supports: a large extended family she is close to, many friends, and her church community",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic household anchored to the public account of her life; no relative is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Very private about her health: wants information shared only with the people she chooses, and wants to keep working through treatment if she can",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic preference anchored to the public accounts that she kept her illness private.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; alcohol occasionally, within low-risk limits; no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Menstrual history: last period about eight years ago; no menopausal hormone therapy, tamoxifen or other hormone use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent and working full time; walks most days",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, direct and precise; asks pointed questions and wants the facts plainly; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Postmenopausal bleeding for three weeks in a 60-year-old journalist, about eight years after her last period and with no hormone use. An office endometrial biopsy was taken today and a transvaginal ultrasound is booked this week. Please see her within two weeks to review both results with her and plan treatment if they show cancer or atypical hyperplasia",
        "urgency": "Within two weeks; sooner if the biopsy shows cancer",
        "pertinent_history": "Spotting, then light bleeding on and off for about three weeks, without pain; last period about eight years ago; no menopausal hormone therapy or tamoxifen. No children. Never smoker. Examination today with a chaperone: blood at the cervical os, normal cervix, uterus mobile and of about normal size, no adnexal mass. Office endometrial biopsy taken today with adequate tissue. Results today: hemoglobin 11.8 g/dL, platelets 268, creatinine 0.82 mg/dL, glucose 94 mg/dL, A1c 5.5%. BMI 27.4. PHQ-2 negative. No medicines; no known allergies. She wants the cause found quickly and told plainly, and she wants her health information shared only with the clinicians caring for her",
        "questions": [
          "If the biopsy shows cancer, what are the histology, grade, molecular class and stage, and what further staging is needed?",
          "What surgery do you recommend, including how the lymph nodes should be assessed?",
          "Which treatment after surgery would the final stage and molecular class call for?",
          "How should Lynch syndrome be screened for, and does she or her blood relatives need genetic testing?",
          "What monitoring should primary care share during and after treatment?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Ifill, 60, is seen at the request of Dr. Achebe-Price two weeks after she first reported three weeks of postmenopausal bleeding. An office endometrial biopsy was taken at that visit, and a transvaginal ultrasound two days later. The biopsy shows endometrioid adenocarcinoma, and CT was done the following week. The bleeding is now occasional spotting; she has no pain, bowel or bladder change, or leg swelling. She takes no hormones. She works long days as a journalist and anchor and wants to keep working through treatment if possible, and to decide who is told",
        "data_reviewed": "Dr. Achebe-Price's intake note. Endometrial biopsy: endometrioid adenocarcinoma, FIGO grade 2; mismatch repair immunohistochemistry with loss of MLH1 and PMS2 and retained MSH2 and MSH6; p53 wild-type pattern. Transvaginal ultrasound: endometrium 16 mm, heterogeneous, with an irregular junction with the myometrium and internal flow; two small intramural fibroids; normal ovaries. CT of the chest, abdomen and pelvis: enlarged uterine cavity; a 1.5 cm right external iliac node and a 1.7 cm left para-aortic node below the renal veins; no liver, lung, bone or peritoneal lesion; no ascites. Today: CA-125 28 U/mL; hemoglobin 12.1 g/dL, platelets 274; creatinine 0.80 mg/dL; albumin 4.1 g/dL",
        "exam": [
          {
            "system": "General",
            "finding": "Well; weight 74.2 kg; blood pressure 132/82, pulse 84"
          },
          {
            "system": "Abdomen",
            "finding": "Soft, non-tender; no mass or fluid"
          },
          {
            "system": "Pelvic",
            "finding": "With a chaperone: small amount of blood at the cervical os; cervix normal; uterus mobile, slightly enlarged; no adnexal mass or parametrial thickening"
          },
          {
            "system": "Lymph nodes",
            "finding": "No inguinal or supraclavicular nodes"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Endometrioid adenocarcinoma of the endometrium, FIGO grade 2, mismatch repair deficient",
            "assessment": "The biopsy shows a low-grade endometrioid cancer that has lost MLH1 and PMS2, with a wild-type p53 pattern. The enlarged right pelvic and left para-aortic nodes on CT suggest stage IIIC disease; the final FIGO 2023 stage comes from surgery. The molecular class needs POLE sequencing on the surgical specimen as well: a POLE-mutated tumor carries an excellent outlook, a p53-abnormal one a poor outlook, and a mismatch repair deficient tumor responds strongly to immunotherapy. She is fit, and the disease on CT can be removed with a minimally invasive operation: total hysterectomy with removal of both tubes and ovaries, washings, sentinel lymph node mapping with indocyanine green, and removal of the enlarged pelvic and para-aortic nodes. If nodal disease is confirmed, I recommend dostarlimab with carboplatin and paclitaxel every three weeks for six cycles, then dostarlimab alone every six weeks for up to three years: for mismatch repair deficient advanced endometrial cancer this combination sharply lowers the risk of progression compared with chemotherapy alone. Radiation would be reserved for nodal disease left after treatment. The loss of MLH1 is the universal Lynch syndrome tumor screen; in most women of her age it comes from MLH1 promoter methylation in the tumor, which is acquired, not inherited. If methylation is found, germline testing is not needed; if it is not, she should have germline testing after counseling, and if a variant is found, her blood relatives should be offered cascade testing through a letter she can share"
          }
        ],
        "recommendations": [
          "Robotic-assisted total laparoscopic hysterectomy with removal of both tubes and ovaries, washings, sentinel lymph node mapping, and removal of the enlarged pelvic and para-aortic nodes, in two weeks",
          "MLH1 promoter methylation testing on the biopsy now; POLE sequencing and estrogen receptor on the surgical specimen; FIGO 2023 stage with the molecular class recorded",
          "Genetic counseling once the methylation result is back; germline testing only if MLH1 loss is not explained by methylation; cascade testing of blood relatives only if a germline variant is found",
          "If nodal disease is confirmed: dostarlimab 500 mg with carboplatin AUC 5 and paclitaxel 175 mg/m2 every 21 days for six cycles, then dostarlimab 1000 mg every six weeks for up to three years, after hepatitis B, hepatitis C and HIV screening",
          "Before each cycle: blood count, kidney and liver function, magnesium, glucose, TSH and free T4, and a morning cortisol; neuropathy and immune-related symptom checks at each visit; three-drug antiemetic prevention",
          "CA-125 is normal and should not be used to follow her; CT of the chest, abdomen and pelvis at the end of combination treatment",
          "Survivorship care after treatment: examination with a pelvic examination every three months for two years and CT every six months for three years for stage III disease, with no routine vaginal cytology; lymphedema checks; distress screening at each visit"
        ],
        "communication": "Discussed with Dr. Achebe-Price, who saw her the same day. The biopsy, ultrasound and CT were explained to Ms. Ifill, who chose surgery in two weeks; she decides who else receives this note",
        "follow_up": "Surgery in two weeks; review with the final pathology and the tumor board recommendation before the first cycle; Dr. Achebe-Price continues primary care and shares the monitoring"
      },
      "guideline_ids": [
        "GL-NCCN-UTERINE-2026",
        "GL-FIGO-2023",
        "GL-RUBY-2023",
        "GL-GY018-2023",
        "GL-JEMPERLI-LABEL",
        "GL-ACOG-PB147",
        "GL-ASCO-IRAE-2021",
        "GL-SGO-SURV-2026",
        "GL-CMID-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Spotting, then light bleeding on and off for about three weeks, eight years after her periods stopped; no pain",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting concern; no symptom of her real illness was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She does not want a wait-and-see answer: she knows that bleeding after menopause is sometimes put down to nothing, and she wants the cause found quickly and told plainly",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern reflecting the documented delays Black women report in the evaluation of postmenopausal bleeding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants to keep working and to decide who is told",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented privacy about her illness.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Endometrial tissue diagnosis and ultrasound within one week, and a gynecologic oncology plan within three weeks of presentation",
        "status": "completed",
        "target_date": "2026-01-20",
        "outcome": "Biopsy at the first visit, ultrasound in two days, result in four days, CT in eight, consultation at two weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Surgical staging within four weeks of diagnosis",
        "status": "completed",
        "target_date": "2026-02-24",
        "outcome": "Minimally invasive hysterectomy with sentinel node mapping and para-aortic node removal two weeks after the consultation",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surgical goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Six cycles of dostarlimab with carboplatin and paclitaxel every three weeks without a delay of more than one week",
        "status": "completed",
        "target_date": "2026-06-30",
        "outcome": "Six cycles on schedule; CT shows no evidence of disease",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Lynch syndrome tumor screening completed and explained before treatment starts",
        "status": "completed",
        "target_date": "2026-02-24",
        "outcome": "MLH1 promoter hypermethylation found: acquired, not inherited; genetic counseling done",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic genetics goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Immune-related adverse events found early: TSH, liver tests, glucose and cortisol checked on schedule",
        "status": "completed",
        "target_date": "2026-06-30",
        "outcome": "Hypothyroidism found on a scheduled TSH and treated without stopping dostarlimab; one missed baseline cortisol recorded and corrected",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "PHQ-9 below 10 throughout treatment, with support she chooses",
        "status": "completed",
        "target_date": "2026-06-30",
        "outcome": "PHQ-9 between 4 and 6",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Gynecologic oncology consultation within two weeks to review the endometrial biopsy and ultrasound with her and plan treatment if cancer or atypical hyperplasia is found",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-UTERINE-2026",
          "GL-ACOG-PMB-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic specialist consultation booked at intake so that a positive result reaches a specialist without delay.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Any bleeding after menopause is evaluated: speculum and bimanual examination, office endometrial biopsy at the first visit, and transvaginal ultrasound within the week, both done rather than relying on endometrial thickness alone; blood count and A1c; results by telephone within days, not at a routine visit",
        "status": "completed",
        "guideline_ids": [
          "GL-ACOG-PMB-2026",
          "GL-ACOG-CO734-2018",
          "GL-DOLL-2020",
          "GL-CLARKE-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic diagnostic pathway; it guards against the delays in evaluating bleeding that contribute to the higher mortality of Black women with endometrial cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Staging and molecular classification: CT of the chest, abdomen and pelvis; mismatch repair immunohistochemistry and p53 on the biopsy, with MLH1 promoter methylation testing for MLH1 loss and POLE sequencing on the surgical specimen; FIGO 2023 stage with the molecular class recorded",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-UTERINE-2026",
          "GL-FIGO-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic staging plan decided when the biopsy showed cancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-004",
        "display": "Robotic-assisted total laparoscopic hysterectomy with removal of both tubes and ovaries, pelvic washings, sentinel lymph node mapping with indocyanine green, and removal of the enlarged pelvic and para-aortic nodes",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-UTERINE-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic surgical plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-005",
        "display": "Lynch syndrome screening of the tumor for every endometrial cancer, with genetic counseling; germline testing if mismatch repair loss is not explained by MLH1 promoter methylation, and cascade testing offered to blood relatives only if a germline variant is found",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-UTERINE-2026",
          "GL-ACOG-PB147",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic genetics plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-01-20"
      },
      {
        "id": "INT-006",
        "display": "Dostarlimab 500 mg with carboplatin (AUC 5) and paclitaxel 175 mg/m2 every three weeks for six cycles, then dostarlimab 1000 mg every six weeks for up to three years, for mismatch repair deficient stage IIIC2 disease; hepatitis B, hepatitis C and HIV screening first; three-drug antiemetic prevention; blood counts, kidney function and magnesium before each cycle; TSH, free T4, liver tests, glucose and morning cortisol at baseline and before each cycle; neuropathy checks at each visit",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-UTERINE-2026",
          "GL-RUBY-2023",
          "GL-JEMPERLI-LABEL",
          "GL-ASCO-IRAE-2021",
          "GL-ASCO-ANTIEMETIC-2020",
          "GL-ASCO-CIPN-2020",
          "GL-ASCO-HBV-2020",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic systemic treatment chosen by the final stage and molecular class.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-02-24"
      },
      {
        "id": "INT-007",
        "display": "Immune-related hypothyroidism: levothyroxine with TSH and free T4 every six weeks, continuing dostarlimab",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-IRAE-2021",
          "GL-JEMPERLI-LABEL",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan for an immune-related adverse event found at the end of combination treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-06-30"
      },
      {
        "id": "INT-008",
        "display": "Survivorship: examination with a pelvic examination every three months for two years, CT of the chest, abdomen and pelvis every six months for three years, no routine vaginal cytology and no CA-125 (normal at diagnosis), teaching on symptoms of recurrence, lymphedema checks, sexual health, weight, activity, blood pressure, lipid and glucose care, distress screening, and age-appropriate screening for other cancers",
        "status": "completed",
        "guideline_ids": [
          "GL-SGO-SURV-2026",
          "GL-NCCN-UTERINE-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic survivorship plan given at the end of combination treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        },
        "recorded_date": "2026-06-30"
      },
      {
        "id": "INT-009",
        "display": "Distress and depression screening at each visit, plain explanations, written information, and support she chooses; she decides who receives each note",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-NCCN-UTERINE-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T19:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-UTERINE-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ACOG-PMB-2026",
        "title": "Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding. Obstet Gynecol 2026;148(1):e87-e91 (PMID 41990335)",
        "publisher": "American College of Obstetricians and Gynecologists",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41990335/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ACOG-CO734-2018",
        "title": "Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol 2018;131(5):e124-e129 (PMID 29683909)",
        "publisher": "American College of Obstetricians and Gynecologists",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29683909/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-FIGO-2023",
        "title": "Berek JS, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 2023;162(2):383-394 (PMID 37337978)",
        "publisher": "International Federation of Gynecology and Obstetrics",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37337978/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-RUBY-2023",
        "title": "Mirza MR, et al. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer (RUBY). N Engl J Med 2023;388(23):2145-2158 (PMID 36972026)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36972026/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-GY018-2023",
        "title": "Eskander RN, et al. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer (NRG-GY018). N Engl J Med 2023;388(23):2159-2170 (PMID 36972022)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36972022/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-JEMPERLI-LABEL",
        "title": "JEMPERLI (dostarlimab-gxly) injection, prescribing information",
        "publisher": "U.S. National Library of Medicine, DailyMed (GlaxoSmithKline label)",
        "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=095eab9f-545a-4f12-bfb7-19477fb901a5",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-SGO-SURV-2026",
        "title": "Salani R, et al. Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecol Oncol 2026;204:109-117 (PMID 41308226)",
        "publisher": "Society of Gynecologic Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41308226/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ACOG-PB147",
        "title": "ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol 2014;124(5):1042-1054 (PMID 25437740)",
        "publisher": "American College of Obstetricians and Gynecologists",
        "url": "https://pubmed.ncbi.nlm.nih.gov/25437740/",
        "version_or_year": "2014"
      },
      {
        "guideline_id": "GL-ASCO-IRAE-2021",
        "title": "Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 2021;39(36):4073-4126 (PMID 34724392)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34724392/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-ANTIEMETIC-2020",
        "title": "Hesketh PJ, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 2020;38(24):2782-2797",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32658626/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-CIPN-2020",
        "title": "Loprinzi CL, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020;38(28):3325-3348",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32663120/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-HBV-2020",
        "title": "Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32716741/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CLARKE-2022",
        "title": "Clarke MA, et al. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype. JAMA Oncol 2022;8(6):895-903 (PMID 35511145)",
        "publisher": "National Cancer Institute investigators (JAMA Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35511145/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-DOLL-2020",
        "title": "Doll KM, et al. Assessment of Prediagnostic Experiences of Black Women With Endometrial Cancer in the United States. JAMA Netw Open 2020;3(5):e204954 (PMID 32412636)",
        "publisher": "JAMA Network Open",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32412636/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, endometrial cancer and hypothyroidism monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BRCA-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-OSTEO-2025",
        "title": "Osteoporosis to Prevent Fractures: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the combined biopsy and ultrasound pathway, the FIGO 2023 stage IIIC2ii with the MMRd molecular class, the choice of dostarlimab with carboplatin and paclitaxel, MLH1 methylation instead of germline testing, the immune-related hypothyroidism managed without stopping dostarlimab, and the survivorship schedule."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what she made public, what was reported during her life, and obituaries and official statements: The Washington Post, CNN, PBS NewsHour, NPR, CBS News and the Associated Press. The stage, histology and treatment of her cancer were never made public; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative is named in the modern episode, and no health fact, decision or genetic result is attributed to any real person."
    }
  }
}
